Intrinsic value of Fluidigm - FLDM

Previous Close

$7.55

  Intrinsic Value

$0.00

stock screener

  Rating & Target

str. sell

-100%

Previous close

$7.55

 
Intrinsic value

$0.00

 
Up/down potential

-100%

 
Rating

str. sell

We calculate the intrinsic value of FLDM stock by summing up the current values of future distributable cash flows generated by the company and dividing the sum by the number of outstanding shares. As such, the intrinsic value calculation depends entirely on projections. The more accurate your projections of the company's performance are - the more reliable is the intrinsic value calculation result. Please make sure to check the stock valuation input data below and adjust it if necessary. The quality of the output (intrinsic valuation result) is only as good as the quality of the input. See also DISCLAIMERS.

STOCK VALUATION INPUT DATA

Revenue (in 0001), $M
Initial revenue growth rate, %
Terminal revenue growth rate, %
Revenue decline factor
Initial discount rate, %
Discount rate multiplier
Variable cost ratio, %
Fixed operating expenses, $M
Interest rate on debt, %
Effective corporate tax rate, %
Production assets / Revenue, %
Life of production assets, yrs
Working capital / Revenue, %
Revenue / Adjusted assets
Adjusted equity ratio
Cash flow adjustment, % of Revenue
Book value of equity, $M
Shares outstanding, mln
Market capitalization, $bln 0.3

 

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year
   2
   3
   4
   5
   6
   7
   8
   9
   10
   11
   12
   13
   14
   15
   16
   17
   18
   19
   20
   21
   22
   23
   24
   25
   26
   27
   28
   29
   30
   31

INCOME STATEMENT

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Revenue growth rate, %
  10.50
  9.95
  9.45
  9.01
  8.61
  8.25
  7.92
  7.63
  7.37
  7.13
  6.92
  6.73
  6.55
  6.40
  6.26
  6.13
  6.02
  5.92
  5.83
  5.74
  5.67
  5.60
  5.54
  5.49
  5.44
  5.39
  5.36
  5.32
  5.29
  5.26
Revenue, $m
  113
  124
  136
  148
  160
  174
  187
  202
  217
  232
  248
  265
  282
  300
  319
  339
  359
  380
  402
  426
  450
  475
  501
  529
  557
  587
  619
  652
  686
  722
Variable operating expenses, $m
  189
  206
  224
  243
  262
  282
  303
  325
  348
  372
  379
  404
  431
  458
  487
  517
  548
  581
  614
  650
  686
  725
  765
  807
  851
  897
  945
  995
  1,048
  1,103
Fixed operating expenses, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Total operating expenses, $m
  189
  206
  224
  243
  262
  282
  303
  325
  348
  372
  379
  404
  431
  458
  487
  517
  548
  581
  614
  650
  686
  725
  765
  807
  851
  897
  945
  995
  1,048
  1,103
Operating income, $m
  -77
  -82
  -89
  -95
  -102
  -109
  -116
  -124
  -131
  -139
  -131
  -139
  -149
  -158
  -168
  -178
  -189
  -200
  -212
  -224
  -237
  -250
  -264
  -278
  -294
  -309
  -326
  -343
  -361
  -380
EBITDA, $m
  -55
  -60
  -66
  -72
  -78
  -85
  -91
  -98
  -106
  -113
  -121
  -129
  -138
  -146
  -156
  -165
  -175
  -185
  -196
  -207
  -219
  -232
  -244
  -258
  -272
  -286
  -302
  -318
  -335
  -352
Interest expense (income), $m
  6
  11
  11
  12
  13
  15
  16
  18
  20
  21
  23
  25
  27
  29
  31
  34
  36
  38
  41
  43
  46
  49
  52
  55
  58
  62
  65
  69
  73
  77
  81
Earnings before tax, $m
  -87
  -93
  -101
  -108
  -117
  -125
  -134
  -143
  -153
  -163
  -156
  -167
  -178
  -189
  -202
  -214
  -227
  -241
  -255
  -270
  -286
  -302
  -319
  -337
  -355
  -374
  -395
  -416
  -438
  -461
Tax expense, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Net income, $m
  -87
  -93
  -101
  -108
  -117
  -125
  -134
  -143
  -153
  -163
  -156
  -167
  -178
  -189
  -202
  -214
  -227
  -241
  -255
  -270
  -286
  -302
  -319
  -337
  -355
  -374
  -395
  -416
  -438
  -461

BALANCE SHEET

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cash and short-term investments, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Total assets, $m
  284
  313
  342
  373
  405
  439
  473
  510
  547
  586
  627
  669
  713
  758
  806
  855
  907
  960
  1,016
  1,075
  1,135
  1,199
  1,266
  1,335
  1,408
  1,484
  1,563
  1,646
  1,733
  1,824
Adjusted assets (=assets-cash), $m
  284
  313
  342
  373
  405
  439
  473
  510
  547
  586
  627
  669
  713
  758
  806
  855
  907
  960
  1,016
  1,075
  1,135
  1,199
  1,266
  1,335
  1,408
  1,484
  1,563
  1,646
  1,733
  1,824
Revenue / Adjusted assets
  0.398
  0.396
  0.398
  0.397
  0.395
  0.396
  0.395
  0.396
  0.397
  0.396
  0.396
  0.396
  0.396
  0.396
  0.396
  0.396
  0.396
  0.396
  0.396
  0.396
  0.396
  0.396
  0.396
  0.396
  0.396
  0.396
  0.396
  0.396
  0.396
  0.396
Average production assets, $m
  114
  126
  138
  150
  163
  176
  190
  205
  220
  236
  252
  269
  286
  305
  324
  344
  364
  386
  408
  432
  456
  482
  509
  537
  566
  596
  628
  662
  697
  733
Working capital, $m
  -2
  -2
  -2
  -3
  -3
  -3
  -3
  -4
  -4
  -4
  -4
  -5
  -5
  -5
  -6
  -6
  -6
  -7
  -7
  -8
  -8
  -9
  -9
  -10
  -10
  -11
  -11
  -12
  -12
  -13
Total debt, $m
  195
  220
  247
  275
  304
  334
  365
  397
  431
  466
  503
  541
  580
  621
  664
  708
  755
  803
  853
  906
  961
  1,018
  1,078
  1,140
  1,206
  1,274
  1,346
  1,420
  1,499
  1,581
Total liabilities, $m
  256
  281
  308
  336
  365
  395
  426
  459
  492
  528
  564
  602
  641
  682
  725
  770
  816
  864
  915
  967
  1,022
  1,079
  1,139
  1,201
  1,267
  1,335
  1,407
  1,482
  1,560
  1,642
Total equity, $m
  28
  31
  34
  37
  41
  44
  47
  51
  55
  59
  63
  67
  71
  76
  81
  86
  91
  96
  102
  107
  114
  120
  127
  133
  141
  148
  156
  165
  173
  182
Total liabilities and equity, $m
  284
  312
  342
  373
  406
  439
  473
  510
  547
  587
  627
  669
  712
  758
  806
  856
  907
  960
  1,017
  1,074
  1,136
  1,199
  1,266
  1,334
  1,408
  1,483
  1,563
  1,647
  1,733
  1,824
Debt-to-equity ratio
  6.850
  7.040
  7.210
  7.360
  7.490
  7.610
  7.710
  7.800
  7.880
  7.960
  8.020
  8.090
  8.140
  8.190
  8.240
  8.280
  8.330
  8.360
  8.400
  8.430
  8.460
  8.490
  8.520
  8.540
  8.570
  8.590
  8.610
  8.630
  8.650
  8.660
Adjusted equity ratio
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100
  0.100

CASH FLOW

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income, $m
  -87
  -93
  -101
  -108
  -117
  -125
  -134
  -143
  -153
  -163
  -156
  -167
  -178
  -189
  -202
  -214
  -227
  -241
  -255
  -270
  -286
  -302
  -319
  -337
  -355
  -374
  -395
  -416
  -438
  -461
Depreciation, amort., depletion, $m
  22
  22
  23
  23
  24
  24
  25
  25
  26
  26
  10
  10
  11
  12
  12
  13
  14
  15
  16
  17
  18
  19
  20
  21
  22
  23
  24
  25
  27
  28
Funds from operations, $m
  -65
  -71
  -78
  -85
  -93
  -101
  -109
  -118
  -127
  -136
  -146
  -156
  -167
  -178
  -189
  -201
  -213
  -226
  -240
  -254
  -268
  -283
  -299
  -316
  -333
  -352
  -371
  -390
  -411
  -433
Change in working capital, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  -1
  -1
  -1
  -1
  -1
  -1
Cash from operations, $m
  -65
  -71
  -78
  -85
  -93
  -101
  -109
  -118
  -127
  -136
  -146
  -156
  -166
  -177
  -189
  -201
  -213
  -226
  -239
  -253
  -268
  -283
  -299
  -315
  -333
  -351
  -370
  -390
  -411
  -432
Maintenance CAPEX, $m
  -4
  -4
  -5
  -5
  -6
  -6
  -7
  -7
  -8
  -8
  -9
  -10
  -10
  -11
  -12
  -12
  -13
  -14
  -15
  -16
  -17
  -18
  -19
  -20
  -21
  -22
  -23
  -24
  -25
  -27
New CAPEX, $m
  -11
  -11
  -12
  -12
  -13
  -13
  -14
  -15
  -15
  -16
  -16
  -17
  -18
  -18
  -19
  -20
  -21
  -22
  -22
  -23
  -24
  -26
  -27
  -28
  -29
  -31
  -32
  -33
  -35
  -37
Cash from investing activities, $m
  -15
  -15
  -17
  -17
  -19
  -19
  -21
  -22
  -23
  -24
  -25
  -27
  -28
  -29
  -31
  -32
  -34
  -36
  -37
  -39
  -41
  -44
  -46
  -48
  -50
  -53
  -55
  -57
  -60
  -64
Free cash flow, $m
  -80
  -86
  -94
  -103
  -112
  -121
  -130
  -140
  -150
  -160
  -171
  -183
  -194
  -207
  -220
  -233
  -247
  -261
  -276
  -292
  -309
  -326
  -344
  -363
  -383
  -403
  -425
  -447
  -471
  -496
Issuance/(repayment) of debt, $m
  0
  25
  27
  28
  29
  30
  31
  33
  34
  35
  36
  38
  39
  41
  43
  44
  46
  48
  50
  53
  55
  57
  60
  63
  65
  68
  72
  75
  78
  82
Issuance/(repurchase) of shares, $m
  114
  96
  104
  112
  120
  128
  137
  147
  157
  167
  160
  171
  182
  194
  206
  219
  232
  246
  261
  276
  292
  308
  326
  344
  362
  382
  403
  424
  447
  470
Cash from financing (excl. dividends), $m  
  114
  121
  131
  140
  149
  158
  168
  180
  191
  202
  196
  209
  221
  235
  249
  263
  278
  294
  311
  329
  347
  365
  386
  407
  427
  450
  475
  499
  525
  552
Total cash flow (excl. dividends), $m
  34
  35
  36
  36
  37
  38
  39
  40
  41
  41
  25
  26
  27
  28
  29
  31
  32
  33
  35
  36
  38
  39
  41
  43
  45
  47
  49
  52
  54
  57
Retained Cash Flow (-), $m
  -114
  -96
  -104
  -112
  -120
  -128
  -137
  -147
  -157
  -167
  -160
  -171
  -182
  -194
  -206
  -219
  -232
  -246
  -261
  -276
  -292
  -308
  -326
  -344
  -362
  -382
  -403
  -424
  -447
  -470
Prev. year cash balance distribution, $m
  30
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash flow adjustment, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash available for distribution, $m
  -51
  -61
  -68
  -75
  -83
  -90
  -99
  -107
  -116
  -125
  -135
  -145
  -155
  -166
  -177
  -188
  -201
  -213
  -226
  -240
  -254
  -269
  -284
  -300
  -317
  -335
  -353
  -373
  -393
  -414
Discount rate, %
  10.40
  10.92
  11.47
  12.04
  12.64
  13.27
  13.94
  14.63
  15.37
  16.13
  16.94
  17.79
  18.68
  19.61
  20.59
  21.62
  22.70
  23.84
  25.03
  26.28
  27.59
  28.97
  30.42
  31.94
  33.54
  35.22
  36.98
  38.83
  40.77
  42.81
PV of cash for distribution, $m
  -46
  -50
  -49
  -48
  -46
  -43
  -40
  -36
  -32
  -28
  -24
  -20
  -17
  -14
  -11
  -8
  -6
  -5
  -3
  -2
  -2
  -1
  -1
  0
  0
  0
  0
  0
  0
  0
Current shareholders' claim on cash, %
  9.6
  7.1
  5.3
  3.9
  3.0
  2.2
  1.7
  1.3
  1.0
  0.7
  0.6
  0.4
  0.3
  0.3
  0.2
  0.2
  0.1
  0.1
  0.1
  0.1
  0.0
  0.0
  0.0
  0.0
  0.0
  0.0
  0.0
  0.0
  0.0
  0.0

Fluidigm Corporation creates, manufactures and markets technologies and life science tools focused on the exploration and analysis of single cells, as well as the industrial application of genomics, based upon the Company's core microfluidics and mass cytometry technologies. The Company operates in the development, manufacturing and commercialization of life science tools for the life science and Ag-Bio industries segment. Its products include preparatory instruments, preparatory analytical instruments, analytical instruments, integrated fluidic circuits (IFCs), and assays and reagents. Its preparatory instruments include C1 Single-Cell Auto Prep System, Access Array System, Juno System and IFCs, and Callisto System and IFC. Its analytical instruments include Biomark HD System, EP1 System and Helios/CyTOF 2 System. Its assays and reagents include Delta Gene and SNP Type Assays, and Access Array Target-Specific Primers and Targeted Sequencing Prep Primers.

FINANCIAL RATIOS  of  Fluidigm (FLDM)

Valuation Ratios
P/E Ratio -2.9
Price to Sales 2.1
Price to Book 4.2
Price to Tangible Book
Price to Cash Flow -5.7
Price to Free Cash Flow -5
Growth Rates
Sales Growth Rate -9.6%
Sales - 3 Yr. Growth Rate %
EPS Growth Rate %
EPS - 3 Yr. Growth Rate %
Capital Spending Gr. Rate -54.5%
Cap. Spend. - 3 Yr. Gr. Rate 0%
Financial Strength
Quick Ratio NaN
Current Ratio 0
LT Debt to Equity 367.9%
Total Debt to Equity 367.9%
Interest Coverage -12
Management Effectiveness
Return On Assets -20.8%
Ret/ On Assets - 3 Yr. Avg. -17.4%
Return On Total Capital -27.2%
Ret/ On T. Cap. - 3 Yr. Avg. -22.5%
Return On Equity -90.5%
Return On Equity - 3 Yr. Avg. -57.9%
Asset Turnover 0.3
Profitability Ratios
Gross Margin 55.8%
Gross Margin - 3 Yr. Avg. 59.6%
EBITDA Margin -53.8%
EBITDA Margin - 3 Yr. Avg. -39.3%
Operating Margin -71.2%
Oper. Margin - 3 Yr. Avg. -53.2%
Pre-Tax Margin -76.9%
Pre-Tax Margin - 3 Yr. Avg. -58.2%
Net Profit Margin -73.1%
Net Profit Margin - 3 Yr. Avg. -55%
Effective Tax Rate 5%
Eff/ Tax Rate - 3 Yr. Avg. 5.8%
Payout Ratio 0%

FLDM stock valuation input parameters

Revenue. Company's revenue (or sales) is always the starting point of any cash flow forecast. In the FLDM stock intrinsic value calculation we used $101.937 million for the last fiscal year's total revenue generated by Fluidigm. The default revenue input number comes from 0001 income statement of Fluidigm. You may change it if you feel that it should be adjusted for some unusual circumstances that are not expected to be repeated in the future or if you already know (from interim financial statements, for example) that this year's revenue is going to be quite different.

Revenue growth rate. Forecasted future revenue growth rate is the most important input parameter for the intrinsic value calculation. Unlike other input parameters that are reasonably expected to be in line with their historic averages or their historic trends, the revenue growth rate by and large is a wild card: nobody really knows what the company's revenue will be in the future. Of course, the level of unpredictability is different for different industries (utility companies being the most predictable and, thus, less risky).
    We use three input parameters to forecast the revenue growth rate in our FLDM stock valuation model: a) initial revenue growth rate of 10.5% whose default value is the revenue growth rate in the most recent quarter compared to the quarterly revenue a year ago; b) terminal revenue growth rate of 5% whose default value is chosen to be close to the average nominal (i.e. not adjusted for inflation) GDP growth rate; and c) revenue decline factor of 0.9, which stipulates that revenue growth rate in each forecasted year will be equal to the difference of the revenue growth rate in the preceding year and the terminal revenue growth rate multiplied by this revenue decline factor (with the passage of time the revenue growth rate will be approaching the terminal revenue growth rate, but not quite reaching it - though the difference could be infinitesimally small).
    At the revenue decline factor of 1, the future revenue growth rate is forecasted to be constant and equal to the initial revenue growth rate. The smaller the revenue decline factor, the faster the revenue growth rate will approach the terminal revenue growth.

Discount rate. The discount rate is used for determining the present value of future cash flows: future cash flows are "discounted" as at normal conditions (that translate into positive expected return on investment) one dollar today is worth more than the same dollar in the future. Unlike all other valuation models, we use variable discount rate, i.e. it increases for each consecutive year. This is done to account for higher risk of cash flows coming in further in the future.
    The initial discount rate of 10.4%, whose default value for FLDM is calculated based on our internal credit rating of Fluidigm, is applied to the cash flow expected to be received a year from now (well, actually, to be precise, in the financial year following the base year - the last year for which we have financial statements). For each consecutive year the discount rate is multiplied by the discount rate multiplier of 1.05, e.i. each year it increases by 5%. Feel free to change this number to correspond to your level of risk assessment of Fluidigm.
    By the way, it is easy to set the discount rate to be constant (this would make comparison with other valuation models easier): just set the discount rate multiplier equal to 1 and chose the magnitude of the initial discount rate to your liking.

Variable cost ratio is the ratio of variable costs (i.e. costs that fluctuate with fluctuation of the volume of production) to the revenue expressed as a percentage. In the calculation of intrinsic value of FLDM stock the variable cost ratio is equal to 169.6%.

Fixed operating expenses is just that - expenses that are not dependant on the volume of production. They are set to $0 million in the base year in the intrinsic value calculation for FLDM stock. These expenses increase with the level of inflation in subsequent years.

Interest rate on debt is the average all-in rate of interest paid by the company on its debt. It is set at 5.4% for Fluidigm.

Corporate tax rate of 27% is the nominal tax rate for Fluidigm. In reality, companies find ways to pay much less taxes than that or not to pay them at all.

Cash flow adjustment could be used for any adjustment the investor deems necessary. Most commonly we use this field to account for stock options-related effects in excess of what is reported on the company's income statement. The cash flow adjustment is expressed as a percentage of the revenue, and in the current valuation of the FLDM stock is equal to 0%.

Production assets are the company's assets used for manufacturing products or provision of services. In the valuation model input table they are expressed as a percentage of revenue and for FLDM are equal to 101.5%.

Life of production assets of 26 years is the average useful life of capital assets used in Fluidigm operations. It is used to calculate yearly capital expenditures needed to keep these assets in good order - we call it the maintenance CAPEX.

Working capital is the difference between the company's current assets and liabilities. In the model we use the ratio of working capital to revenue, which for FLDM is equal to -1.8%. A negative number means that the company is apt at using financial resources of its suppliers and customers; a large positive number, on the other hand, means that it either provides in-kind financing to others or is not good at managing its inventories.

Book value of equity - $30.935 million for Fluidigm - is used in calculation of the "floor" for intrinsic valuation based on the discounted cash flow (DCF) method. Even if the prospects are very bad for a company, its assets could always be sold now for their current fair market value.

Shares outstanding of 39.164 million for Fluidigm is needed to calculate the intrinsic value of one share.

Market capitalization is used here only for reference purposes and as a quick check that the share price and the number of shares outstanding numbers are correct - something especially to be cognizant about at stock splits. So, the market capitalization of Fluidigm at the current share price and the inputted number of shares is $0.3 billion.

RELATED COMPANIES Price Int.Val. Rating
PKI PerkinElmer 79.60 108.15  buy
NSTG NanoString Tec 15.51 0.34  str.sell
TMO Thermo Fisher 235.08 199.97  hold
A Agilent Techno 63.47 100.49  str.buy
PACB Pacific Biosci 7.62 0.16  str.sell
ILMN Illumina 308.23 182.51  sell
BIO Bio-Rad Labora 268.28 323.94  hold

COMPANY NEWS

▶ Fluidigm Recognized as a Company to Watch in 2019   [Nov-07-18 04:11PM  GlobeNewswire]
▶ Fluidigm: 3Q Earnings Snapshot   [06:43PM  Associated Press]
▶ Laura Clague Named to Fluidigm Board of Directors   [Oct-31-18 08:30AM  GlobeNewswire]
▶ Fluidigm: 2Q Earnings Snapshot   [05:05AM  Associated Press]
▶ Fluidigm Announces Second Quarter 2018 Financial Results   [Aug-02-18 04:05PM  GlobeNewswire]
▶ Fluidigm to Participate in Upcoming Investor Events   [May-09-18 04:05PM  GlobeNewswire]
▶ Fluidigm: 1Q Earnings Snapshot   [May-03-18 06:14PM  Associated Press]
▶ Fluidigm Announces Exchange of Convertible Notes   [Mar-02-18 07:45AM  GlobeNewswire]
▶ Fluidigm reports 4Q loss   [Feb-08-18 09:07PM  Associated Press]
▶ Fluidigm to Report Q4 and Full Year 2017 Financial Results   [Jan-25-18 04:05PM  GlobeNewswire]
▶ ETFs with exposure to Fluidigm Corp. : January 1, 2018   [Jan-01-18 11:35AM  Capital Cube]
▶ ETFs with exposure to Fluidigm Corp. : December 19, 2017   [Dec-19-17 01:01PM  Capital Cube]
▶ ETFs with exposure to Fluidigm Corp. : December 7, 2017   [Dec-07-17 01:44PM  Capital Cube]
▶ ETFs with exposure to Fluidigm Corp. : November 27, 2017   [Nov-27-17 01:37PM  Capital Cube]
▶ Fluidigm reports 3Q loss   [Nov-02-17 06:19PM  Associated Press]
▶ ETFs with exposure to Fluidigm Corp. : October 25, 2017   [Oct-25-17 09:58AM  Capital Cube]
▶ Fluidigm to Unveil High-Parameter Tissue Imaging System   [Oct-18-17 09:00AM  GlobeNewswire]
▶ ETFs with exposure to Fluidigm Corp. : October 11, 2017   [Oct-11-17 11:31AM  Capital Cube]
▶ ETFs with exposure to Fluidigm Corp. : August 25, 2017   [Aug-25-17 04:26PM  Capital Cube]
▶ Fluidigm reports 2Q loss   [Aug-05-17 01:10AM  Associated Press]
▶ ETFs with exposure to Fluidigm Corp. : July 10, 2017   [Jul-10-17 02:29PM  Capital Cube]
▶ ETFs with exposure to Fluidigm Corp. : June 16, 2017   [Jun-16-17 03:47PM  Capital Cube]
▶ ETFs with exposure to Fluidigm Corp. : June 2, 2017   [Jun-02-17 02:08PM  Capital Cube]

CONTACT US       ASSET ALLOCATION

About X-FIN       Site news       Privacy policy       Terms of use       FAQ

Copyright © X-FIN.com 2005-2018. All rigths reserved.